文献速递心境障碍精神分裂症与精神病性障碍物质与行为成瘾

美国精神健康与物质使用障碍支出分析

Mental Health and Substance Use Disorder Expenditures in the US.
PubMed 文献 · JAMA Psychiatry · 2026-09-30

心境障碍和焦虑障碍的总体支出最高,而物质使用障碍、精神分裂症和双相障碍的人均治疗支出最高。

要点

  • 物质使用障碍人均治疗支出最高(9569美元)。

核心结论

  • 美国精神健康支出在人群和人均层面差异大,但相对于精神障碍的社会负担持续偏低。

主要发现

  • 精神健康支出总体人均523美元,任何治疗精神障碍者人均2473美元。
  • 人均治疗支出最高为物质使用障碍9569美元、精神分裂症9370美元、双相障碍7382美元。

临床怎么用

  • 政策制定者可参考支出分布优化精神健康资源分配。
  • 临床需关注高人均支出的物质使用障碍、精神分裂症和双相障碍患者。
  • 研究应致力于更有效治疗、减少低价值护理并匹配患者损伤与适当护理级别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Understanding spending on mental health could help inform policymakers on decisions about where to direct mental health care resources and help evaluate whether spending aligns with public health priorities. Despite this, the magnitude and distribution of mental health expenditures in the US remain poorly characterized. OBJECTIVE: To estimate aggregate mental health expenditures by sociodemographic characteristics, type of insurance, mental health disorders, and type of service. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional analysis of the 2021-2023 Medical Expenditure Panel Survey (MEPS), an annual, nationally representative survey of the civilian noninstitutionalized US population. Analyses focused on individuals who made at least 1 outpatient mental health visit in 2021, 2022, or 2023. Data analysis was conducted from August 2025 to January 2026. EXPOSURE: Outpatient mental health visits. MAIN OUTCOMES AND MEASURES: Overall and per-100-person expenditures stratified by sociodemographic characteristics and diagnostic categories. RESULTS: The analysis included all survey participants (N = 67 532 person-year observations; mean [SD] age, 39.8 [0.25] years; 35 608 [50.7%] female) and identified those with reported outpatient mental health visits in 2021, 2022, and 2023 (n = 15 407; mean [SD] age, 45.0 [0.36] years; 9500 [60.0%] female). The estimated annualized aggregate total health care expenditures as measured in the MEPS in 2021-2023 were $2.5 trillion (95% CI, $2.3 trillion to $2.7 trillion), with $174 billion (95% CI, $152 billion to $196 billion) in mental health expenditures representing 7.0% (95% CI, 6.4%-7.7%) of all medical expenditures. This represented an annual mean of $523 (95% CI, $474-$571) per person overall and $2473 (95% CI, $2266-$2679) per person among those with any treated mental health disorder. Mood disorders and anxiety and fear-related disorders accounted for the highest aggregate expenditures ($74 billion [95% CI, $62 billion to $86 billion] and $69 billion [95% CI, $58 billion to $81 billion], respectively). Expenditures per treated individual were highest for substance use disorders ($9569 [95% CI, $6943-$12 195]), schizophrenia ($9370 [95% CI, $6685-$12 055]), and bipolar disorders ($7382 [95% CI, $6027-$8737]). Overall, expenditures on ambulatory services accounted for $107 billion (95% CI, $93 billion to $121 billion), while expenditures on medication accounted for $36 billion (95% CI, $31 billion to $40 billion) and those for home health care and inpatient treatment accounted for $20 billion (95% CI, $11 billion to $29 billion) and $12 billion (95% CI, $8 billion to $15 billion), respectively. CONCLUSIONS AND RELEVANCE: This cross-sectional study found that expenditures on mental health disorders in the US vary widely at the per-person and population levels, but they are consistently low relative to the societal burden of mental disorders. Research that leads to more effective treatments, decreases provision of low-value care, and supports better matching of patients' impairment with the appropriate level of care could help optimize treatment access while controlling expenditures.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Blanco C, McClellan C, Zuvekas SH, et al. Mental Health and Substance Use Disorder Expenditures in the US. JAMA Psychiatry. 2026. PMID: 42814455. doi:10.1001/jamapsychiatry.2026.3120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。